The 10 Biggest Stories Of 2023 That Say The Future Is Here
From the first licensed CRISPR medicine to unprecedented climate migration, these are the top 10 news stories of 2023 that have profound implications for the future.
Source: forbes.com
Page 21 - Crispr News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Crispr Today - Breaking & Trending Today
9 hospitals cleared to deliver new CRISPR-based sickle cell treatment
FDA approves 1st CRISPR gene therapy to treat sickle cell disease. Nine hospitals have been authorized to offer the one-time treatment by Vertex Pharmaceuticals
Source: beckershospitalreview.com
Is Genome Editing the Next Step in Immunotherapy Innovation? Experts Think So
Presenters at the American Society of Hematology Annual Meeting and Exposition agreed that novel strategies, such as CRISPR and base editing, have potential to fine-tune the latest immunotherapy advancements to increase the efficacy and durability of a range of treatments.
Source: ajmc.com
US FDA approves first CRISPR-based gene therapy Casgevy for sickle cell; Lyfgenia gets nod, too
Both Vertex Pharmaceuticals Inc.’s Casgevy (exagamglogene autotemcel, exa-cel) and Bluebird Bio Inc.’s Lyfgenia (lovotibeglogene autotemcel, lovo-cel) received U.S. FDA approval Dec. 8, providing 16,000 American sickle cell patients who have recurring vaso-occlusive events with access to the first cell-based gene therapies.
Source: bioworld.com
Crispr Gene Editing: FDA Could Approve First Genetic Therapy That Might Cure Sickle Cell
The Food and Drug Administration is expected to approve a new gene editing therapy for sickle cell disease, its first green light for a Crispr treatment.
Source: forbes.com